Authors
Loading...
Analysis reveals unique mutational signatures and immune characteristics in pancreatic ductal adenocarcinoma with germline ATM variants, suggesting targeted therapies may be beneficial.
Yadav et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: